Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[NF-kappa B and cancers].

V Bours

    Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
    |September 19, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Many breast cancers overexpress NF-kappa B inhibitor p100, blocking anti-cancer gene expression. Gene therapy using suicide and cytokine genes shows promise for colorectal cancer treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome.

    Frontiers in genetics·2023
    Same author

    Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer: A Belgian expert opinion.

    Facts, views & vision in ObGyn·2022
    Same author

    [Heredity and cancer].

    Revue medicale de Liege·2021
    Same author

    [Current and new therapeutic options in inborn errors of metabolism].

    Revue medicale de Liege·2020
    Same author

    [(S)un (M)ay (A)rise on SMA : the hope of a region without spinal muscular atrophy].

    Revue medicale de Liege·2019
    Same author

    [Study of cancer risks associated with Lynch syndrome in the Liège region].

    Revue medicale de Liege·2019
    Same journal

    [Belgium Royal Academy of Medicine membership list].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2015
    Same journal

    Massively parallel sequencing: a new tool in virus discovery and vaccine safety.

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
    Same journal

    New viral pathogens from wildlife.

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
    Same journal

    Liver transplantation or Starzl's legacy. A look backward, a look forward.

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
    Same journal

    [The creation of a vascularized tracheal transplantation].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
    Same journal

    [Molecular dialogue between African trypanosomes and humans].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2012
    See all related articles

    Area of Science:

    • Molecular Biology
    • Oncology
    • Gene Therapy

    Context:

    • Nuclear factor kappa B (NF-kappa B) is a transcription factor crucial for cell proliferation, survival, and oncogenesis.
    • Aberrant NF-kappa B signaling is implicated in various cancers, including breast and colorectal cancers.
    • The inhibitor protein p100 plays a significant role in regulating NF-kappa B activity.

    Purpose:

    • To investigate the role of NF-kappa B and its inhibitor p100 in breast cancer.
    • To explore the mechanisms controlling NF-kappa B activity in different cell types.
    • To evaluate a novel gene therapy strategy for peritoneal carcinomatosis.

    Summary:

    • High levels of the NF-kappa B inhibitor p100 were observed in breast cancers, where it sequesters NF-kappa B, preventing gene induction.

    Related Experiment Videos

  • Mechanisms regulating NF-kappa B differ between adenocarcinoma and lymphoid cells.
  • NF-kappa B activation by chemotherapy did not alter p53 induction or cytotoxicity in tested cell lines.
  • A gene therapy approach combining the HSV-TK suicide gene and cytokine genes (IL-12 or GM-CSF) demonstrated therapeutic efficacy in a preclinical model of colorectal peritoneal carcinomatosis.

    • Impact:

    • Findings elucidate NF-kappa B dysregulation in breast cancer and suggest potential therapeutic targets.
    • The study validates a dual-gene therapy strategy for enhancing anti-cancer effects in peritoneal carcinomatosis.
    • This research contributes to the development of innovative gene therapy approaches for solid tumors.